Cargando…
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
BACKGROUND: Cachexia is a complex metabolic syndrome associated with cancer. One of the features of cachexia is the loss of muscle mass, characterized by an imbalance between protein synthesis and protein degradation. Muscle atrophy is caused by the hyperactivation of some of the main cellular catab...
Autores principales: | Musolino, Vincenzo, Palus, Sandra, Tschirner, Anika, Drescher, Cathleen, Gliozzi, Micaela, Carresi, Cristina, Vitale, Cristiana, Muscoli, Carolina, Doehner, Wolfram, von Haehling, Stephan, Anker, Stefan D., Mollace, Vincenzo, Springer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864048/ https://www.ncbi.nlm.nih.gov/pubmed/27239419 http://dx.doi.org/10.1002/jcsm.12116 |
Ejemplares similares
-
Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011) -
Febuxostat improves outcome in a rat model of cancer cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015) -
MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020) -
Cardiac expression of neutrophil gelatinase‐associated lipocalin in a model of cancer cachexia‐induced cardiomyopathy
por: Musolino, Vincenzo, et al.
Publicado: (2018) -
IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011)